Gene · 2913
NIH grants1,644
NIH grants whose papers are about the gene, through NIH's grant-paper links.
301 to 320 of 1,644
Download this page as JSON| Grant | Title | GRM3 papers | Newest fiscal year |
|---|---|---|---|
| ZIAHG000136 | Functional genomic analysis of neural crest development | 1 | 2023 |
| T32GM007628 | Training in Pharmacological Sciences | 5 | 2022 |
| R01MH100141 | Estimating the genetic and environmental architecture of psychiatric disorders | 3 | 2022 |
| R37MH057881 | Genetics Association in Schizophrenia and Other Disorders | 3 | 2022 |
| I01BX002395 | Dissecting cis regulation of gene expression in schizophrenia. | 2 | 2022 |
| P01CA206980 | Integration of Clinical and Molecular Biomarkers for Melanoma Survival | 2 | 2022 |
| P50MH090964 | Antecedents of Suicidal Behavior Related Neurobiology | 2 | 2022 |
| R01DA033049 | Cortical Plasticity in Methamphetamine Addiction | 2 | 2022 |
| T32GM008181 | Training Program in Integrative Membrane Biology | 2 | 2022 |
| K00MH122943 | Pyramidal neuron hypoactivity in schizophrenia cortex | 1 | 2022 |
| K02ES029119 | New Mechanism of Arsenic Carcinogenesis | 1 | 2022 |
| K08NS102468 | The role of skin BDNF in the maintenance of the cutaneous mechanosensory nervous system | 1 | 2022 |
| OT2OD025337 | Research Matters: Creating Possibilities to Achieve Health and Wellness for All of Us Research Program | 1 | 2022 |
| OT2OD026550 | Trans-America Consortium of the Health Care Systems Research Network for the All of Us Research Program | 1 | 2022 |
| P20GM103645 | Center for Central Nervous System Function | 1 | 2022 |
| P30GM122734 | Phase III COBRE: Multimodal Imaging of Neuropsychiatric Disorders (MIND) | 1 | 2022 |
| P41EB015922 | Laboratory of Neuro Imaging Resource (LONIR) | 1 | 2022 |
| R01AG060393 | An Integrative Multi-Omics Approach to Elucidate Sex-Specific Differences in Alzheimers Disease | 1 | 2022 |
| R01AI114975 | Characterization and disruption of bacterial microcompartment shells from human pathogens | 1 | 2022 |
| R01CA112314 | Mechanism and Anti-Cancer Activity of SCFA-Hexosamine Analogs | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2913/grants?page=16